1.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BIOS-012010, NCT01374373
|
|
2.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR005143, EPOANE3010, 2005-001817-17, NCT00338286
|
|
3.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: ECOG-E2905, E2905, NCT00843882
|
|
4.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR018367, EPOANE3021, 2010-022884-36, NCT01381809
|
|
5.
|
Phase: Phase II Type: Supportive care Status: Active Age: 40 to 59 Sponsor: Other Protocol IDs: NA_00010941, NCT00737893
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CLBH589BDE04, EudraCT 2009-010403-84, NCT01034657
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NMDSG08A, 2009-011483-11, NCT01048034
|
|
8.
|
Phase: Phase II Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: SMD-TXAGO, NCT01356875
|